KDM5A

lysine demethylase 5A, the group of AT-rich interaction domain containing|PHD finger proteins|EMSY complex|Lysine demethylases

Basic information

Region (hg38): 12:280057-389320

Previous symbols: [ "RBBP2", "JARID1A" ]

Links

ENSG00000073614NCBI:5927OMIM:180202HGNC:9886Uniprot:P29375AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital heart disease (Limited), mode of inheritance: AD
  • El Hayek-Chahrour neurodevelopmental disorder (Limited), mode of inheritance: AR
  • neurodevelopmental disorder (Limited), mode of inheritance: AD
  • neurodevelopmental disorder (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
El Hayek-Chahrour neurodevelopmental syndromeARCardiovascularAmong other findings, the condition may involve congenital cardiovascular anomalies, and awareness may allow early identification and managementCardiovascular; Neurologic33350388

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KDM5A gene.

  • not_specified (139 variants)
  • not_provided (81 variants)
  • KDM5A-related_disorder (15 variants)
  • El_Hayek-Chahrour_neurodevelopmental_disorder (7 variants)
  • Seizure (3 variants)
  • Intellectual_disability (3 variants)
  • See_cases (2 variants)
  • KDM5A-associated_neurodevelopmental_syndrome (1 variants)
  • KDM5A-related_Neurodevelopmental_disorder_with_autism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KDM5A gene is commonly pathogenic or not. These statistics are base on transcript: NM_001042603.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
12
clinvar
3
clinvar
18
missense
1
clinvar
1
clinvar
184
clinvar
5
clinvar
5
clinvar
196
nonsense
1
clinvar
2
clinvar
4
clinvar
7
start loss
1
1
frameshift
1
clinvar
6
clinvar
7
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
14
clinvar
16
Total 4 5 211 17 8

Highest pathogenic variant AF is 0.000015497744

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KDM5Aprotein_codingprotein_codingENST00000399788 28109326
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.003.78e-91251780161251940.0000639
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.257189090.7900.000050711118
Missense in Polyphen134271.670.493253412
Synonymous-2.663843231.190.00001693216
Loss of Function7.94888.70.09020.000005091047

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00007970.0000793
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.0003310.000329

dbNSFP

Source: dbNSFP

Function
FUNCTION: Histone demethylase that specifically demethylates 'Lys- 4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Regulates specific gene transcription through DNA-binding on 5'-CCGCCC-3' motif (PubMed:18270511). May stimulate transcription mediated by nuclear receptors. Involved in transcriptional regulation of Hox proteins during cell differentiation (PubMed:19430464). May participate in transcriptional repression of cytokines such as CXCL12. Plays a role in the regulation of the circadian rhythm and in maintaining the normal periodicity of the circadian clock. In a histone demethylase-independent manner, acts as a coactivator of the CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER1/2 and other clock-controlled genes and increases histone acetylation at PER1/2 promoters by inhibiting the activity of HDAC1 (By similarity). Seems to act as a transcriptional corepressor for some genes such as MT1F and to favor the proliferation of cancer cells (PubMed:27427228). {ECO:0000250|UniProtKB:Q3UXZ9, ECO:0000269|PubMed:11358960, ECO:0000269|PubMed:15949438, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17320163, ECO:0000269|PubMed:18270511, ECO:0000269|PubMed:19430464, ECO:0000269|PubMed:27427228}.;
Pathway
HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization (Consensus)

Recessive Scores

pRec
0.161

Intolerance Scores

loftool
0.0591
rvis_EVS
-0.74
rvis_percentile_EVS
13.79

Haploinsufficiency Scores

pHI
0.604
hipred
Y
hipred_score
0.793
ghis
0.571

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.835

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kdm5a
Phenotype
cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; immune system phenotype; neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;chromatin remodeling;spermatogenesis;male gonad development;circadian regulation of gene expression;histone H3-K9 demethylation;histone H3-K4 demethylation;histone H3-K4 demethylation, trimethyl-H3-K4-specific;positive regulation of transcription, DNA-templated;regulation of DNA-binding transcription factor activity;oxidation-reduction process;negative regulation of histone deacetylase activity
Cellular component
nucleus;nucleoplasm;nucleolus;protein-DNA complex;histone methyltransferase complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;core promoter sequence-specific DNA binding;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;zinc ion binding;chromatin DNA binding;histone demethylase activity;histone demethylase activity (H3-K9 specific);histone demethylase activity (H3-trimethyl-K4 specific);histone demethylase activity (H3-dimethyl-K4 specific);methylated histone binding;histone binding;dioxygenase activity